Chengwei Evergreen Capital, LP - Net Worth and Insider Trading

Chengwei Evergreen Capital, LP Net Worth

The estimated net worth of Chengwei Evergreen Capital, LP is at least $96 Million dollars as of 2024-11-11. Chengwei Evergreen Capital, LP is the 2101 Beneficial owner of TOT Biopharm International Co Ltd and owns about 56,573,500 shares of TOT Biopharm International Co Ltd (HKSE:01875) stock worth over $96 Million. Details can be seen in Chengwei Evergreen Capital, LP's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chengwei Evergreen Capital, LP has not made any transactions after 2022-12-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Chengwei Evergreen Capital, LP

Chengwei Evergreen Capital, LP Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chengwei Evergreen Capital, LP owns 1 companies in total, including TOT Biopharm International Co Ltd (HKSE:01875) .

Click here to see the complete history of Chengwei Evergreen Capital, LP’s form 4 insider trades.

Insider Ownership Summary of Chengwei Evergreen Capital, LP

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01875	TOT Biopharm International Co Ltd	2022-12-28	2101 Beneficial owner

Chengwei Evergreen Capital, LP Latest Holdings Summary

Chengwei Evergreen Capital, LP currently owns a total of 1 stock. Chengwei Evergreen Capital, LP owns 56,573,500 shares of TOT Biopharm International Co Ltd (HKSE:01875) as of December 28, 2022, with a value of $96 Million.

Latest Holdings of Chengwei Evergreen Capital, LP

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01875	TOT Biopharm International Co Ltd	2022-12-28	56,573,500	1.70	96,174,950

Holding Weightings of Chengwei Evergreen Capital, LP

Chengwei Evergreen Capital, LP Form 4 Trading Tracker

According to the SEC Form 4 filings, Chengwei Evergreen Capital, LP has made a total of 1 transactions in TOT Biopharm International Co Ltd (HKSE:01875) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in TOT Biopharm International Co Ltd is the sale of 0 shares on December 28, 2022, which brought Chengwei Evergreen Capital, LP around $0.

Insider Trading History of Chengwei Evergreen Capital, LP

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Chengwei Evergreen Capital, LP Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Chengwei Evergreen Capital, LP Ownership Network

Ownership Network List of Chengwei Evergreen Capital, LP

No Data

Ownership Network Relation of Chengwei Evergreen Capital, LP

Chengwei Evergreen Capital, LP Owned Company Details

What does TOT Biopharm International Co Ltd do?

Who are the key executives at TOT Biopharm International Co Ltd?

Chengwei Evergreen Capital, LP is the 2101 Beneficial owner of TOT Biopharm International Co Ltd. Other key executives at TOT Biopharm International Co Ltd include 2201 Interest of corporation controlled by you Center Laboratories, Inc. , 2301 Trustee Tricor Trust (hong Kong) Limited , and 2101 Beneficial owner Center Laboratories Inc. .

TOT Biopharm International Co Ltd (HKSE:01875) Insider Trades Summary

Over the past 18 months, Chengwei Evergreen Capital, LP made no insider transaction in TOT Biopharm International Co Ltd (HKSE:01875). Other recent insider transactions involving TOT Biopharm International Co Ltd (HKSE:01875) include a net sale of 0 shares made by Center Laboratories, Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TOT Biopharm International Co Ltd (HKSE:01875) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TOT Biopharm International Co Ltd (HKSE:01875)'s detailed insider trading history can be found in Insider Trading Tracker table.

TOT Biopharm International Co Ltd Insider Transactions

No Available Data

Chengwei Evergreen Capital, LP Mailing Address

Above is the net worth, insider trading, and ownership report for Chengwei Evergreen Capital, LP. Currently GuruFocus does not have mailing address information for Chengwei Evergreen Capital, LP.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.